Raymond James Financial’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39M Buy
431,967
+51,473
+14% +$4.36M 0.01% 1074
2026
Q1
$31.6M Sell
380,494
-30,317
-7% -$2.49M 0.01% 1150
2025
Q4
$37.8M Sell
410,811
-2,352
-0.6% -$225K 0.01% 1002
2025
Q3
$39.2M Sell
413,163
-11,842
-3% -$1.11M 0.01% 957
2025
Q2
$44.5M Sell
425,005
-8,623
-2% -$817K 0.02% 826
2025
Q1
$38.3M Sell
433,628
-42,949
-9% -$4.4M 0.01% 866
2024
Q4
$45.7M Buy
+476,577
New +$44.4M 0.02% 769

Other funds holding HQY

Raymond James Financial's HQY Position: Q2 2026 in Review

Raymond James Financial increased its HealthEquity (HQY) stake by 14% in Q2 2026, buying an estimated $4.36M and bringing the position to 431,967 shares worth $39M. The position accounts for 0.01% of the portfolio, ranked #1074.

Raymond James Financial first reported a position in HQY in Q4 2024 and has held it in 7 quarters since. The position peaked at $45.7M in Q4 2024. 501 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Raymond James Financial held 431,967 shares of HealthEquity worth $39M as of Q2 2026.
  • Raymond James Financial bought 51,473 HealthEquity shares in Q2 2026, an estimated $4.36M.
  • HealthEquity made up 0.01% of Raymond James Financial's portfolio in Q2 2026, its #1074 holding.
  • Raymond James Financial first reported a position in HealthEquity in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's HealthEquity position peaked at $45.7M in Q4 2024.
  • 501 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.